Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Why The Volpara (ASX:VHT) Share Price Is Up 4%

Healthcare company Volpara Health Technologies Ltd (ASX:VHT) has seen its share price rise more than 4% this morning. 

Healthcare company Volpara Health Technologies Ltd (ASX: VHT) has seen its share price rise more than 4% this morning.

Volpara describes itself as a ‘MedTech Software as a Service’ company that was founded in 2009 on research conducted at Oxford University. Its software is used for screening clinics to provide feedback on breast density, compression, dose and quality. Its VolparaEnterprise business provides role-specific dashboards and wide-ranging benchmarking analytics to help clinics manage their business more efficiently.

Volpara’s FY20 First Quarter Trading Update

Volpara is presenting at the Bioshares Biotech Summit in Queenstown today and decided to include an update about its first quarter of FY20.

The company said that it has reached NZ$14.6 million of annualised recurring revenue (ARR). Volpara also said that it is on track to meet its guidance for the financial year of NZ$17.1 million.

After the recent MRS Systems acquisition, the company’s combined US market share has reached approximately 25%.

The MRS systems acquisition increased the number of US breast clinics to which the company has access to from around 400 to over 2,000, being an increase of around 400%.

The idea of the acquisition is that it will provide stronger technical expertise, a significant increase of ARR, accelerated sales through cross-selling opportunities and increased potential average revenue per user (ARPU) through new products.

Is Volpara A Buy?

These days the best growth shares are tech shares that have high profit margins, a good amount of recurring revenue, support attractive industries with the software and have a good growth runway.

I think Volpara fits this description but I’m not sure how big its market opportunity is. I certainly think it could create more growth outside of the US. Canada and Europe would be attractive additional locations to expand in.

I’m not sure if Volpara is nicely priced at today’s value, low interest rates make it a difficult environment to invest in. But I do think it’s worth watching along with the two growth shares in the free report below.

[ls_content_block id=”14947″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content